Furthermore, this dual role of claudin-4 was associated with ovarian tumor cell resistance to genome instability formation and cell death by a known genomic instability-inducing agent, such as the PARP inhibitor olaparib (31, 32). The gene discussed is CLDN4; the disease is ovarian neoplasm.